Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Diabetes

  Free Subscription


04.05.2026

1 Acta Ophthalmol
1 Am J Cardiol
1 Am J Manag Care
1 Am J Med
1 Am J Nephrol
1 Biochem Biophys Res Commun
2 BMC Ophthalmol
1 Circulation
9 Diabet Med
3 Diabetes
4 Diabetes Care
7 Diabetes Obes Metab
5 Diabetologia
1 Invest Ophthalmol Vis Sci
1 J Diabetes Complications
1 J Nutr
3 Kidney Int
1 Med Care
2 Nat Genet
3 Nature
1 Nutr Metab (Lond)
1 Ophthalmology
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Ophthalmol

  1. MASCHORECK LG, Stokholm L, Pedersen FN, Andersen N, et al
    The impact of coronary artery bypass grafting on the short- and long-term development and progression of diabetic retinopathy: A Danish national matched cohort study.
    Acta Ophthalmol. 2026 Apr 30. doi: 10.1111/aos.70147.
    PubMed         Abstract available


    Am J Cardiol

  2. MORTADA I, Lee A, Sahu A, Vidal E, et al
    Differential Outcomes with Empagliflozin and Dapagliflozin in Heart Failure with Mildly Reduced Ejection Fraction with and without Diabetes Mellitus.
    Am J Cardiol. 2026 Apr 23:S0002-9149(26)00259.
    PubMed         Abstract available


    Am J Manag Care

  3. GOOD CB, Beren IA, Rosenberg EM, Peasah SK, et al
    Medication use for patients with obesity: trends and characteristics for US employees.
    Am J Manag Care. 2026;32:238-244.
    PubMed         Abstract available


    Am J Med

  4. GOLDHABER SZ, Rashedi S, Pfeferman M, Leyva H, et al
    Electronic Alert-Based Computerized Decision Support for Detection of Chronic Kidney Disease in Type 2 Diabetes Mellitus: The CKD-DETECT Randomized Trial.
    Am J Med. 2026 Apr 22:S0002-9343(26)00297-4. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available


    Am J Nephrol

  5. NIU Q, Zhou K, Zhang T
    Recent Advances and Future Directions in the Mechanisms and Therapeutic Strategies Targeting the Complement System in Diabetic Nephropathy.
    Am J Nephrol. 2026 Apr 28:1-19. doi: 10.1159/000551634.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  6. SONG W, Dong Y, Wang X, Xu F, et al
    Chiglitazar prevents diabetes-induced skeletal muscle loss by enhancing myogenic differentiation through the MEK/ERK pathway.
    Biochem Biophys Res Commun. 2026;819:153768.
    PubMed         Abstract available


    BMC Ophthalmol

  7. JOO T, Joo JH
    Serial aqueous VEGF analysis for predicting anti-VEGF treatment outcomes in neovascular glaucoma from diabetic retinopathy: a prospective analysis.
    BMC Ophthalmol. 2026 Apr 29. doi: 10.1186/s12886-026-04852.
    PubMed        

  8. CHEN Y, Chen N, Meng X, Linghu M, et al
    Correlation between the expression levels of miR-199a-3p and FN1 in serum and aqueous humor and the severity of type 2 diabetic retinopathy in a Chinese population.
    BMC Ophthalmol. 2026;26:220.
    PubMed         Abstract available


    Circulation

  9. SUMIYOSHI T, Iijima K, Fujiki S, Hirabayashi K, et al
    Effect of Empagliflozin on Device-Measured Thoracic Impedance in Patients With Type 2 Diabetes Treated With an Implantable Cardioverter Defibrillator.
    Circulation. 2026;153:1343-1346.
    PubMed        


    Diabet Med

  10. PENG X, Gu S, Liu J, Kong D, et al
    Protective effects of 23-valent pneumococcal polysaccharide vaccination against mortality among elder patients with type 2 diabetes mellitus.
    Diabet Med. 2026 Apr 30:e70341. doi: 10.1111/dme.70341.
    PubMed         Abstract available

  11. WEE Z, Bee YM, Zainudin SB
    The burden of diabetic foot ulcers in a multi-ethnic Asian cohort.
    Diabet Med. 2026 Apr 24:e70335. doi: 10.1111/dme.70335.
    PubMed         Abstract available

  12. ABILD CB, Knudsen JH, Schodt M, Gribsholt SB, et al
    Implementing Diabetes Eating Problem Survey - Revised in pediatric type 1 diabetes care: Clinician reflections on systematic screening and multidisciplinary management.
    Diabet Med. 2026 Apr 26:e70333. doi: 10.1111/dme.70333.
    PubMed         Abstract available

  13. NYBO PF, Nielsen NV, Mouritsen JD, Roder ME, et al
    Interventions for binge eating disorder in adults with type 2 diabetes: A systematic review.
    Diabet Med. 2026 Apr 26:e70346. doi: 10.1111/dme.70346.
    PubMed         Abstract available

  14. JOHNSON VL, Hall V, Berrington R, Burdon J, et al
    Expert considerations to guide the development and delivery of an exercise intervention in people with type 2 diabetes-related foot ulcer disease.
    Diabet Med. 2026 Apr 30:e70338. doi: 10.1111/dme.70338.
    PubMed         Abstract available

  15. GOLDNEY J, Hamza M, Sarkar P, Morgan H, et al
    Evaluation of a secondary care multidisciplinary clinic for adults with early-onset type 2 diabetes at high risk in Leicester, Leicestershire and Rutland.
    Diabet Med. 2026 Apr 30:e70347. doi: 10.1111/dme.70347.
    PubMed         Abstract available

  16. AKINBOBOYE O, Walker RJ, Campbell JA, Hawks L, et al
    The relationship between pre-incarceration related social determinants and glycaemic control in African Americans with criminal legal involvement and type 2 diabetes.
    Diabet Med. 2026 Apr 26:e70342. doi: 10.1111/dme.70342.
    PubMed         Abstract available

  17. POPOVIC DS, Koufakis T
    Has the time come for a remission definition in type 1 diabetes? A functional perspective.
    Diabet Med. 2026 Apr 29:e70351. doi: 10.1111/dme.70351.
    PubMed        

  18. DIAS RP, Marcovecchio ML, Willemsen RH, Campbell F, et al
    Considerations for the clinical use of teplizumab in stage 2 Type 1 diabetes: A Consensus Statement from the British Society of Paediatric Endocrinology and Diabetes (BSPED) and the Association of British Clinical Diabetologists (ABCD).
    Diabet Med. 2026 Apr 29:e70329. doi: 10.1111/dme.70329.
    PubMed         Abstract available


    Diabetes

  19. YANG Y, Teng S, Zhang Y, Ji YH, et al
    Lysosomal Ion Channel TRPML1 Contributes to Neuropathic Pain Associated With Diabetic Peripheral Neuropathy in Mice.
    Diabetes. 2026 Apr 30:db250901. doi: 10.2337/db25-0901.
    PubMed         Abstract available

  20. DAO GM, Zhao S, Schofield C, Vogrin S, et al
    Whey Protein Ingestion Stimulates Glucagon Secretion and Raises Blood Glucose Levels in Adults With Type 1 Diabetes.
    Diabetes. 2026 Apr 24:db260059. doi: 10.2337/db26-0059.
    PubMed         Abstract available

  21. RODRIGUEZ-CALVO T, Martinez-Sanchez A
    miRNAs in Islet Biology and Diabetes: Progress, Gaps, and Opportunities.
    Diabetes. 2026 Apr 30:db250977. doi: 10.2337/db25-0977.
    PubMed         Abstract available


    Diabetes Care

  22. FAN Y, Wu H, Lau ESH, Shi M, et al
    Associations of General Adiposity, Abdominal Adiposity and Their Changes With Fracture Risk in Chinese Individuals With Type 2 Diabetes: A Population-Based Cohort Study in Hong Kong.
    Diabetes Care. 2026 Apr 30:dc260261. doi: 10.2337/dc26-0261.
    PubMed         Abstract available

  23. SIMS EK, Skyler JS, Jacobsen LM, Ismail HM, et al
    C-Peptide Provides Critical Contextual Insight Into Elevated Glucose Values During Progression to Type 1 Diabetes.
    Diabetes Care. 2026 Apr 30:dci260022. doi: 10.2337/dci26-0022.
    PubMed         Abstract available

  24. CHONG KH, Ahmadi MN, Biswas RK, Francois ME, et al
    Dose-Response Associations of Intermittent Lifestyle Physical Activity Micropatterns and Incident Type 2 Diabetes.
    Diabetes Care. 2026 Apr 28:dc253018. doi: 10.2337/dc25-3018.
    PubMed         Abstract available

  25. QIANG J, Pathmaraj M, Lo T, Uleryk EM, et al
    The Effectiveness of Diabetes Prevention Programs Delivered in Primary Care for Individuals With Prediabetes or at Risk of Developing Type 2 Diabetes: A Systematic Review and Meta-analysis.
    Diabetes Care. 2026 Apr 24:dc251877. doi: 10.2337/dc25-1877.
    PubMed         Abstract available


    Diabetes Obes Metab

  26. ZHOU D, Liu X, Sun L, Li N, et al
    Association of Metabolic Vulnerability Index With Incident Type 2 Diabetes in General Population and All-Cause Mortality in Patients With Diabetes: A Cohort Study Based on UK Biobank.
    Diabetes Obes Metab. 2026 Apr 27. doi: 10.1111/dom.70789.
    PubMed         Abstract available

  27. BOLLI GB, Home PD, Lepore M, Riddle MC, et al
    The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long-Acting Insulin Analogues for Diabetes Mellitus.
    Diabetes Obes Metab. 2026 Apr 27. doi: 10.1111/dom.70751.
    PubMed         Abstract available

  28. OSCARSSON J, Huhn M, Jiang Y, Gause-Nilsson I, et al
    Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis.
    Diabetes Obes Metab. 2026 Apr 27. doi: 10.1111/dom.70820.
    PubMed         Abstract available

  29. CHEN HJ, Huang EL, Kuang L, Zhang BY, et al
    Accelerometer-Derived 'Weekend Warrior' Physical Activity Pattern and Microvascular Risk in Individuals With Type 2 Diabetes and Prediabetes.
    Diabetes Obes Metab. 2026 Apr 27. doi: 10.1111/dom.70828.
    PubMed         Abstract available

  30. LIU K, Zhu Y, Zhang C, Huang L, et al
    Association Between Maternal Diabetes and the Risk of Cancers in Mother-Offspring: A Meta-Analysis of 44.9 Million Pregnancies.
    Diabetes Obes Metab. 2026 Apr 29. doi: 10.1111/dom.70835.
    PubMed         Abstract available

  31. OH TJ, Kim SS, Lee SH, Kwon HS, et al
    Efficacy and Safety of Pregabalin and Alpha-Lipoic Acid Combination in Patients With Painful Diabetic Peripheral Neuropathy: A Randomized, Open-Label, Non-Inferiority, Phase IV Clinical Trial and Subgroup Analysis (OPTIMUM Study).
    Diabetes Obes Metab. 2026 Apr 29. doi: 10.1111/dom.70795.
    PubMed         Abstract available

  32. AGUREE S, Silveyra P, Liu N, Owora AH, et al
    Coexisting Asthma and Diabetes Are Associated With Adverse Metabolic and Inflammatory Profiles.
    Diabetes Obes Metab. 2026 Apr 26. doi: 10.1111/dom.70767.
    PubMed         Abstract available


    Diabetologia

  33. MEEKS KAC, van der Linden EL, Bentley AR, Doumatey AP, et al
    Causal relationship between epigenetic markers and type 2 diabetes in West African populations: a Mendelian randomisation analysis.
    Diabetologia. 2026 Apr 24. doi: 10.1007/s00125-026-06716.
    PubMed         Abstract available

  34. CHEPULIS L, Gan H, Simmons D, Rodrigues M, et al
    SGLT2 inhibitor use and disparities in all-cause mortality in type 2 diabetes: insights from a multi-ethnic population.
    Diabetologia. 2026 Apr 27. doi: 10.1007/s00125-026-06733.
    PubMed         Abstract available

  35. WANG Y, Isasi CR, Stuebe AM, Louis-Jacques AF, et al
    Gestational diabetes and risk of type 2 diabetes: exploring the role of the gut microbiome in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Diabetologia. 2026 Apr 30. doi: 10.1007/s00125-026-06727.
    PubMed         Abstract available

  36. QUINN LM, Stanley D, Milano F, Perego G, et al
    Psychosocial implications, acceptability and ethics of screening for paediatric type 1 diabetes: a systematic review and mixed methods evidence synthesis.
    Diabetologia. 2026 May 1. doi: 10.1007/s00125-026-06717.
    PubMed         Abstract available

  37. CHEN SY, Lekka C, Lemvig J, Yi X, et al
    From pancreas and islet resources to diabetes insights.
    Diabetologia. 2026 May 1. doi: 10.1007/s00125-026-06731.
    PubMed         Abstract available


    Invest Ophthalmol Vis Sci

  38. LI X, Luo L, Chen S, Sun Y, et al
    PANK4 Regulates YAP to Modulate the Glycolytic Pathway in LEC for Driving LECs-EMT in Early Diabetic Cataract Pathogenesis.
    Invest Ophthalmol Vis Sci. 2026;67:66.
    PubMed         Abstract available


    J Diabetes Complications

  39. BLOMQVIST JM, Eriksson MI, Harjutsalo V, Smidtslund P, et al
    Association between chronic low-grade inflammation and metabolic syndrome and their impact on the risk of coronary artery disease in type 1 diabetes.
    J Diabetes Complications. 2026;40:109331.
    PubMed         Abstract available


    J Nutr

  40. RADER A, Buckman C, Pignone M, German JC, et al
    Factors Associated with Produce Prescription Program Enrollment and Benefit Use Among Patients with Diabetes and At Risk for Food Insecurity.
    J Nutr. 2026 Apr 24:101548. doi: 10.1016/j.tjnut.2026.101548.
    PubMed         Abstract available


    Kidney Int

  41. CAZA TN, Charu V, Dai DF, Davis VG, et al
    Clinical and Histologic Predictors of Non-Diabetic Kidney Disease in Patients with Diabetes Mellitus.
    Kidney Int. 2026 Apr 23:S0085-2538(26)00305-4. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available

  42. QI Z, Tang Y, Croy JE, Wilson JM, et al
    Reversal of advanced diabetic kidney disease in mice treated with a monoclonal anti-VEGFR1 antibody.
    Kidney Int. 2026 Apr 24:S0085-2538(26)00306-6. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available

  43. FERREIRA RM, Gisch DL, Phillips CL, Cheng YH, et al
    A MEF2C transcription factor network regulates proliferation of glomerular endothelial cells in diabetic kidney disease.
    Kidney Int. 2026 Apr 27:S0085-2538(26)00310-8. doi: 10.1016/j.kint.2026.
    PubMed         Abstract available


    Med Care

  44. HEINTZMAN JD, Dinh D, Kaufmann J, Lucas J, et al
    The Paradoxical Association of Disaggregated Data Collection With Diabetes Control Among Latino Patients.
    Med Care. 2026 Apr 27. doi: 10.1097/MLR.0000000000002331.
    PubMed         Abstract available


    Nat Genet

  45. MCGRAIL C, Sears TJ, Griffin EN, Ghaben AL, et al
    Genetic association and machine learning improve the prediction of type 1 diabetes risk.
    Nat Genet. 2026 Apr 30. doi: 10.1038/s41588-026-02578.
    PubMed         Abstract available

  46. LI Y, Polychronakos C
    Machine learning in prediction and classification of type 1 diabetes.
    Nat Genet. 2026 Apr 30. doi: 10.1038/s41588-026-02571.
    PubMed        


    Nature

  47. LISKIEWICZ D, Novikoff A, Khalil A, Akindehin S, et al
    GLP-1R-GIPR-PPARalpha/gamma/delta quintuple agonism corrects obesity and diabetes in mice.
    Nature. 2026 Apr 29. doi: 10.1038/s41586-026-10427.
    PubMed         Abstract available

  48. DUMOULIN B, Levinsohn J, Klotzer KA, Li C, et al
    Spatial atlas of diabetic kidney disease reveals a B cell-rich subgroup.
    Nature. 2026 Apr 29. doi: 10.1038/s41586-026-10363.
    PubMed         Abstract available


  49. A cell atlas charts the immune architecture of diabetic kidney disease.
    Nature. 2026 Apr 29. doi: 10.1038/d41586-026-01177.
    PubMed        


    Nutr Metab (Lond)

  50. YUAN Z, Lao G, Liu J, Jian Y, et al
    Relationship between low phase angle and impaired healing of diabetic foot ulcer: a retrospective cohort study.
    Nutr Metab (Lond). 2026 Apr 25. doi: 10.1186/s12986-026-01126.
    PubMed        


    Ophthalmology

  51. YANG S, Xin Z, Liu B, Huang Y, et al
    Decoding Gene-Lifestyle Synergy in Diabetic Retinopathy Development: A Transethnic Prospective Cohort Study.
    Ophthalmology. 2026 Apr 27:S0161-6420(26)00286.
    PubMed         Abstract available


    PLoS One

  52. VILAR-LLUCH S, Knight D
    Type 1 and Type 2 diabetes in the UK press: A diachronic corpus-based analysis.
    PLoS One. 2026;21:e0348079.
    PubMed         Abstract available

  53. BERCHIE RO, Inker LA, Heerspink HJL, Haaland B, et al
    Implications of acute change in estimated Glomerular Filtration Rate (eGFR) for the effect of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) on long-term endpoints.
    PLoS One. 2026;21:e0347741.
    PubMed         Abstract available

  54. FU Q, Li J, Gu X, Zhang Y, et al
    Artemether ameliorates type 1 diabetic liver injury alongside the associated defects in mitochondrial ultrastructure and central carbon metabolism.
    PLoS One. 2026;21:e0348214.
    PubMed         Abstract available

  55. CHEN L, Zhu M, Liu X, Wei Q, et al
    Hydrogel-based co-culture and application of two types of islet cells.
    PLoS One. 2026;21:e0347425.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum